- Home
- PEN vs H Comparison
PEN vs H Comparison
Compare PEN & H Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- H
- Stock Information
- Founded
- PEN 2004
- H 1957
- Country
- PEN United States
- H United States
- Employees
- PEN N/A
- H N/A
- Industry
- PEN Medical/Dental Instruments
- H Hotels/Resorts
- Sector
- PEN Health Care
- H Consumer Discretionary
- Exchange
- PEN Nasdaq
- H Nasdaq
- Market Cap
- PEN 10.9B
- H 12.8B
- IPO Year
- PEN 2015
- H 2009
- Fundamental
- Price
- PEN $266.93
- H $132.08
- Analyst Decision
- PEN Strong Buy
- H Buy
- Analyst Count
- PEN 16
- H 17
- Target Price
- PEN $299.73
- H $149.41
- AVG Volume (30 Days)
- PEN 554.0K
- H 1.1M
- Earning Date
- PEN 07-29-2025
- H 05-01-2025
- Dividend Yield
- PEN N/A
- H 0.45%
- EPS Growth
- PEN N/A
- H 23.10
- EPS
- PEN 1.08
- H 7.89
- Revenue
- PEN $1,240,100,000.00
- H $3,216,000,000.00
- Revenue This Year
- PEN $14.60
- H $112.35
- Revenue Next Year
- PEN $14.17
- H $5.56
- P/E Ratio
- PEN $247.65
- H $16.74
- Revenue Growth
- PEN 13.17
- H N/A
- 52 Week Low
- PEN $148.00
- H $102.43
- 52 Week High
- PEN $310.00
- H $168.20
- Technical
- Relative Strength Index (RSI)
- PEN 39.77
- H 59.69
- Support Level
- PEN $260.38
- H $129.94
- Resistance Level
- PEN $275.41
- H $132.68
- Average True Range (ATR)
- PEN 9.23
- H 2.96
- MACD
- PEN -2.51
- H -0.26
- Stochastic Oscillator
- PEN 15.55
- H 50.00
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About H Hyatt Hotels Corporation
Hyatt is an operator of owned (3% of total rooms) and managed and franchised (97%) properties across about 30 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 63% Americas, 15% rest of world, and 22% Asia-Pacific.